715 related articles for article (PubMed ID: 6315819)
1. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
[TBL] [Abstract][Full Text] [Related]
3. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of paf-acether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells.
Ninio E; Joly F; Hieblot C; Bessou G; Mencia-Huerta JM; Benveniste J
J Immunol; 1987 Jul; 139(1):154-60. PubMed ID: 3584983
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
Razin E; Ihle JN; Seldin D; Mencia-Huerta JM; Katz HR; LeBlanc PA; Hein A; Caulfield JP; Austen KF; Stevens RL
J Immunol; 1984 Mar; 132(3):1479-86. PubMed ID: 6198393
[TBL] [Abstract][Full Text] [Related]
8. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
9. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
[TBL] [Abstract][Full Text] [Related]
10. Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen.
Joly F; Bessou G; Benveniste J; Ninio E
Eur J Pharmacol; 1987 Dec; 144(2):133-9. PubMed ID: 2963750
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
[TBL] [Abstract][Full Text] [Related]
12. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
13. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells.
Katz HR; Raizman MB; Gartner CS; Scott HC; Benson AC; Austen KF
J Immunol; 1992 Feb; 148(3):868-71. PubMed ID: 1309842
[TBL] [Abstract][Full Text] [Related]
14. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.
DuBuske L; Austen KF; Czop J; Stevens RL
J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype.
Stevens RL; Bloes WF; Seldin DC; Razin E; Katz HR; Austen KF
J Immunol; 1984 Nov; 133(5):2674-80. PubMed ID: 6332858
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of paf-acether. Activators of protein kinase C stimulate cultured mast cell acetyltransferase without stimulating paf-acether synthesis.
Joly F; Vigrain I; Bossant MJ; Bessou G; Benveniste J; Ninio E
Biochem J; 1990 Oct; 271(2):501-7. PubMed ID: 2146953
[TBL] [Abstract][Full Text] [Related]
17. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
Moqbel R; Macdonald AJ; Cromwell O; Kay AB
Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
19. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells.
Phillips MJ; Gold WM; Goetzl EJ
J Immunol; 1983 Aug; 131(2):906-10. PubMed ID: 6306109
[TBL] [Abstract][Full Text] [Related]
20. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.
Cluzel M; Undem BJ; Chilton FH
J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
